Hopital Foch

hopital-foch.com

Total trials

210

Active

20

Phase 3

9

Total enrollment

43,888

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 9 of 9 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Ursolvan1
GnRH agonist1
Rituximab1
Metformin1
Temozolomide1
Dostarlimab1
Vitamin D31
mFOLFIRINOX Treatment Regimen1
LV5FU21

Next readouts

  • 2025-07-16
  • 2026-06-18
  • 2027-05
  • 2028-02-18
  • 2028-05

Top conditions

  • Anesthesia27
  • Pain8
  • Surgery7
  • Anesthesia, General7
  • General Anesthesia6
  • Covid194
  • Lung Transplant4
  • Bladder Cancer4

Frequently asked questions about Hopital Foch

How many clinical trials does Hopital Foch have on ClinicalTrials.gov?
Hopital Foch is listed as the lead sponsor on 210 clinical trials in ClinicalTrials.gov, 20 of which are currently active (recruiting, enrolling, or ongoing).
How many of Hopital Foch's trials are in Phase 3?
9 of Hopital Foch's trials are in Phase 3, spread across 9 active drug programs.
What therapeutic areas does Hopital Foch focus on?
Hopital Foch's most-studied conditions on ClinicalTrials.gov are Anesthesia, Pain, Surgery, Anesthesia, General, General Anesthesia.
When are Hopital Foch's next clinical trial readouts?
Hopital Foch has 5 upcoming primary-completion readouts tracked here; the soonest is “Evaluation of Glucocorticoids Plus Rituximab in Patients with Newly-Diagnosed or Relapsing IgA Vasculitis”, expected around 2025-07-16.